Cowen & Co. Maintains Outperform on TransMedics Group, Lowers Price Target to $28

Cowen & Co. maintains TransMedics Group (NASDAQ:TMDX) with a Outperform and lowers the price target from $40 to $28.

Benzinga · 11/07/2019 14:11

Cowen & Co. maintains TransMedics Group (NASDAQ:TMDX) with a Outperform and lowers the price target from $40 to $28.